Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer

Clinical trial NCT00504153 · COMPLETED

Trial details

NCT number: NCT00504153
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Colon Cancer Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer

Start date: 2007-07-01
Primary completion: 2011-06-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.